Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > Read the bottom!
View:
Post by FREEDOM55 on Nov 05, 2021 4:59pm

Read the bottom!

US Food and Drug Administration

Coronavirus (COVID-19) Update: November 5, 2021

The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:

  • Today, Friday, November 5, 2021, the FDA authorized another over-the-counter (OTC) COVID-19 test. The FDA issued an emergency use authorization (EUA) for the iHealth COVID-19 Antigen Rapid Test, an OTC COVID-19 antigen diagnostic test that delivers results in 15 minutes. The company anticipates producing 100 million tests per month, with capacity increasing to 200 million per month in early 2022.
    • The test can be used as:
      • A single test for people with COVID-19 symptoms.
      • A serial test for people without symptoms, meaning the test is done two times over three days.
    • The test can be used for people:
      • Age 15 years or older with a self-collected nasal swab sample.
      • Age 2 years or older when an adult collects the nasal swab sample.
    • The FDA is committed to increasing the availability of appropriately accurate and reliable at-home COVID-19 diagnostic tests and to facilitating consumer access to these tests.
  •  
Comment by FREEDOM55 on Nov 05, 2021 5:00pm
The FDA is committed to increasing the availability of appropriately accurate and reliable at-home COVID-19 diagnostic tests and to facilitating consumer access to these tests.
Comment by Zimmee1 on Nov 06, 2021 10:07am
https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19.html COVID-19 in Canada November 5, 2021, 7:05 p.m. EST Total tests performed 46,679,607 Total cases 1,727,686 Active cases 23,425 Recovered 1,675,129 Deaths 29 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities